Qualified healthcare providers can assess your suitability for peptide therapy, determine appropriate dosing, and monitor for potential side effects or interactions with existing medications
Walk-ins and same-day appointments are welcomed and even encouraged
Cardiovascular Outcome Trial (SUSTAIN-6): Major Adverse CV Events The SUSTAIN-6 trial [63] showed that OW semaglutide significantly reduced the risk of major adverse cardiovascular events (MACE) by 26% compared to placebo in patients with T2D
If you want a clearer framework for using peptides intelligently, start with the Injury, Joint & Recovery Blueprint
Neuroimaging data have revealed that diabetes patients often present with white matter damage and reduced brain volumes, which may be a consequence of BBB injury [3]
NAD+ Often taken earlier in the day to support cellular energy production, mitochondrial function, and active metabolism